1. Single anastomosis gastric bypass for morbid obesity.
- Author
-
Richardsen AJ, Chahal-Kummen M, Kristinsson JA, Søvik TT, Eribe IEL, and Mala T
- Subjects
- Humans, Female, Middle Aged, Male, Retrospective Studies, Prospective Studies, Treatment Outcome, Obesity, Morbid surgery, Obesity, Morbid complications, Gastric Bypass adverse effects, Diabetes Mellitus, Type 2 surgery, Diabetes Mellitus, Type 2 complications
- Abstract
Background: Mini-gastric bypass is a new surgical method for the treatment of morbid obesity. The method was introduced at Oslo University Hospital in 2016., Material and Method: We performed a retrospective analysis of prospective data collected over a two-year period following mini-gastric bypass between 1 March 2016 and 1 April 2021., Results: Altogether, 241/1611 (15 %) patients who underwent surgery at the Centre for Morbid Obesity in the five-year period received a mini-gastric bypass. A total of 147/241 (61 %) met the inclusion criteria and 125/147 (85 %) were included in the study. Average age was 47.4 years (standard deviation 10.7), and 81/125 (64.8 %) were women. Average weight was 134 (25) kg before and 90 (20) kg after surgery. Total average weight loss two years after surgery was 33.1 % (9.1). Before surgery and two years post-surgery, 20.0 % and 27.2 % had gastroesophageal reflux, 38.3 % and 8.8 % had type II diabetes and 84.8 % and 44.0 % had dyslipidaemia, respectively. Altogether, 12 % developed anaemia, 6.3 % iron deficiency and 23.1 % vitamin D deficiency. Early complications (< 30 days) were recorded in 6/125 (4.8 %) patients and late complications (> 30 days) in 7/125 (5.6 %) patients. The results were comparable to all the quality indicators in the Scandinavian Obesity Surgery Registry Norway., Interpretation: Mini-gastric bypass can be performed with few complications and with a beneficial effect on secondary comorbidity up to two years after surgery.
- Published
- 2023
- Full Text
- View/download PDF